sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

A Kaur, MR Webster, K Marchbank, R Behera, A Ndoye… - Nature, 2016 - nature.com
Cancer is a disease of ageing. Clinically, aged cancer patients tend to have a poorer
prognosis than young. This may be due to accumulated cellular damage, decreases in …
被引用次数：365 相关文章

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.

A Kaur, MR Webster, K Marchbank, R Behera, A Ndoye… - Nature, 2016 - sonar.ch
English Cancer is a disease of ageing. Clinically, aged cancer patients tend to have a
poorer prognosis than young. This may be due to accumulated cellular damage, decreases …
[HTML] nih.gov

[HTML][HTML] sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

A Kaur, MR Webster, K Marchbank, R Behera, A Ndoye… - Nature, 2016 - ncbi.nlm.nih.gov
Cancer is a disease of aging, and aged cancer patients have a poorer prognosis. This may
be due to accumulated cellular damage, decreases in adaptive immunity, and chronic …

SFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

A Kaur, MR Webster, K Marchbank… - …, 2016 - mdanderson.elsevierpure.com
Cancer is a disease of ageing. Clinically, aged cancer patients tend to have a poorer
prognosis than young. This may be due to accumulated cellular damage, decreases in …

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

A Kaur, MR Webster, K Marchbank, R Behera, A Ndoye… - Nature, 2016 - escholarship.org
Cancer is a disease of ageing. Clinically, aged cancer patients tend to have a poorer
prognosis than young. This may be due to accumulated cellular damage, decreases in …

[引用][C] sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

A Kaur, MR Webster, K Marchbank, R Behera, A Ndoye… - Nature, 2016 - cir.nii.ac.jp
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

SFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

A Kaur, MR Webster, K Marchbank, R Behera… - …, 2016 - scholars.northwestern.edu
Cancer is a disease of ageing. Clinically, aged cancer patients tend to have a poorer
prognosis than young. This may be due to accumulated cellular damage, decreases in …

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.

A Kaur, MR Webster, K Marchbank, R Behera, A Ndoye… - Nature, 2016 - europepmc.org
Cancer is a disease of aging, and aged cancer patients have a poorer prognosis. This may
be due to accumulated cellular damage, decreases in adaptive immunity, and chronic …

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.

A Kaur, MR Webster, K Marchbank, R Behera, A Ndoye… - Nature, 2016 - folia.unifr.ch
English Cancer is a disease of ageing. Clinically, aged cancer patients tend to have a
poorer prognosis than young. This may be due to accumulated cellular damage, decreases …

SFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

A Kaur, MR Webster, K Marchbank, R Behera, A Ndoye… - Nature, 2016 - pure.psu.edu
Cancer is a disease of ageing. Clinically, aged cancer patients tend to have a poorer
prognosis than young. This may be due to accumulated cellular damage, decreases in …